Florida Cancer Specialists & Research Institute (FCS) recently expanded its molecular testing capabilities at its state-of-the-art Pathology Laboratory in Fort Myers and is providing patients with clinical next-generation sequencing (NGS) that are offered at FCS clinics throughout Florida. NGS testing is available for testing of solid tumors and hematologic malignancies and lymph nodes.
Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that Michael Diaz, MD will assume the role of President & Managing Physician, effective January 1, 2022. He succeeds Lucio Gordan, MD, who has served in that position since 2018. Dr. Gordan will continue to practice as a medical oncologist at the FCS Gainesville Cancer Center and serve as Chief Medical Officer of Therapeutics and Analytics for the statewide practice.
Senior leaders of Florida Cancer Specialists & Research Institute (FCS) have been invited to serve on the faculty for the Association for Value-Based Cancer Care 2021 Summit & Educational Program being held in New York, NY on Oct. 13 – 15.
FCS clinical oncology nutritionist Rhone M. Levin, M.Ed, RDN, CSO, LDN, FAND, is the author of the nutrition chapter featured in the recently published 5th Edition of Lung Cancer Choices.
Sarah Cannon recently opened its newest drug development unit in collaboration with FCS and The University of Central Florida College of Medicine in Lake Nona, Fla.
A panel of medical experts recently provided the latest updates about COVID-19 and fielded questions from local residents. COVID-19: Speaking from Science, presented by Florida Cancer Specialists & Research Institute (FCS) in partnership with the Leesburg Area Chamber of Commerce, the City of Leesburg and Red Apples Media was held on Saturday, Aug. 28.